These nanoparticles induced glioma-associated myeloid cell phagocytosis of tumor cells via CD47–PD-L1 ligation, and activation of T cell–supportive myeloid cell phenotypes due to STING agonist–mediated effects. Here, STING1 is linked to central nervous system cancer.